Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block in Patients Undergoing Primary Total Hip Arthoplasty: a Prospective, Double-blinded, Randomized Controlled Trial

NCT06557044 is registered in ClinicalTrials.gov with Diakonie-Klinikum Stuttgart as lead sponsor.

NCT NCT06557044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06557044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block in Patients Undergoing Primary Total Hip Arthoplasty: a Prospective, Double-blinded, Randomized Controlled Trial
Lead sponsor
Diakonie-Klinikum Stuttgart
Phase
Not applicable
Overall status
Recruiting
Start date
March 7, 2024
Completion date
March 31, 2025
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

double-blind, prospective, randomized